Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation.
Recently, we described a platelet antibody against a putative collagen receptor (P62), which was found in a patient with idiopathic thrombocytopenic purpura (ITP) (Blood 69:1712). We now report a deficiency of the P62 receptor in a young man whose platelets showed defective collagen-induced platelet aggregation. He had a mild bleeding tendency and slight thrombocytopenia. The results of coagulation and fibrinolysis studies were normal. The patient's platelets were partially unresponsive to collagen, although aggregation in response to ADP, thrombin, ristocetin, and calcium ionophore (A23187) was almost normal. Adhesion of his platelets to bovine collagen was markedly reduced. Addition of collagen caused no synthesis of thromboxane (TX)B2 in platelet rich plasma (PRP) from this patient. Furthermore, collagen produced no rise of cytosolic free calcium ([Ca2+]i) in fura2-loaded platelets. In contrast, thrombin caused TXB2 formation and an increase of [Ca2+]i in his platelets. These results suggest defective interaction between the platelets and collagen. The IgG from the ITP-patient induced irreversible aggregation in normal PRP, but caused no aggregation of the young man's platelets. Immunoblot studies showed that normal platelets had antigens with a molecular weight of 62 KDa under reducing conditions and of 57 KDa under nonreducing conditions. In contrast, the young man's platelets had no P62 band, although GPIa/IIa and thrombospondin were normally present. These results indicate that impaired collagen-induced aggregation in the patient's platelets was due to a deficiency of P62 and confirm that P62 may play a crucial role as a collagen receptor in platelet activation.
Ryo
R
R
Blood Transfusion Service, Kobe University School of Medicine, Japan.
Yoshida
A
A
Sugano
W
W
Yasunaga
M
M
Nakayama
K
K
Saigo
K
K
Adachi
M
M
Yamaguchi
N
N
Okuma
M
M
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D001792:Blood Platelets / Q000737:chemistry* / Q000378:metabolism / Q000648:ultrastructure; D002118:Calcium / Q000032:analysis / Q000378:metabolism; D003094:Collagen / Q000502:physiology*; D015180:Electrophoresis, Gel, Two-Dimensional; D006801:Humans; D015151:Immunoblotting; D007074:Immunoglobulin G / Q000502:physiology; D037102:Lectins; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D010980:Platelet Membrane Glycoproteins / Q000032:analysis; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000503:physiopathology; D011956:Receptors, Cell Surface / Q000032:analysis* / Q000502:physiology; D038981:Receptors, Collagen; D019699:Thrombospondins; D013929:Thromboxane B2 / Q000378:metabolism
D007074:Immunoglobulin G; D037102:Lectins; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D038981:Receptors, Collagen; D019699:Thrombospondins; D013929:Thromboxane B2; D000255:Adenosine Triphosphate; D003094:Collagen; D002118:Calcium